Radiofrequency ablation of hepatocellular carcinoma in patients with decompensated cirrhosis: Evaluation of therapeutic efficacy and safety

American Journal of Roentgenology

Volumn 186, Issue 5 SUPPL., 2006, Pages

  Young, Kon Kim ^a   Chong, Soo Kim ^a   Gyong, Ho Chung ^a   Young, Min Han ^a   Sang, Yong Lee ^a   Gong, Yong Jin ^a   Lee, Jeong Min ^b,c  

^a Chonbuk National University Medical School   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c NONE   (South Korea)

Author keywords

Cirrhosis; Decompensation; Hepatocellular carcinoma; Liver; Radiofrequency ablation

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE EXACERBATION; ECHOGRAPHY; FEMALE; FOLLOW UP; GENERATOR; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NODULE; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR NECROSIS;

ADULT; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 33846292933     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1266     Document Type: Article

References (36)

1. Tsukama H, Hijama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328:1797-1801
2. Akriviadis EA, Llovert JM, Efremidis SC, et al. Hepatocellular carcinoma. Br J Surg 1998; 85:1319-1331
3. Nadig DE, Wade TP, Fairchild RB, Virgo KS, Johnson FE. Major hepatic resection. Arch Surg 1997; 132:115-119
4. Hoover H Jr. Surgical resection of primary hepatoma and hepatic metastases. Semin Intervent Radiol 1993; 10:169-174
5. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219:236-247
6. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163:387-394
7. Livarghi T, Giogio A, Martin G, et al. Hepatocellular carcinoma in cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 1995; 17:101-108
8. Ohnishi K, Ohyama M, Ito S, Fujita K. Ultrasound guided intratumor injection of acetic acid for the treatment of small hepatocellular carcinoma. Radiology 1994; 193:747-752
9. Goldberg SN, Galelle GS, Dawson SL, Rittman WJ, Mueller PF, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 1995; 2:670-674
10. Caspani B, Cecconi P, Bottelli R, et al. The interstitial photocoagulation with laser light of liver tumors [in Italian]. Radiol Med (Torino) 1997; 94:346-354
11. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74:817-825
12. Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR 1995; 164:1159-1164
13. Everson GT. Treatment of chronic hepatitis C in patients with decompensated cirrhosis. Rev Gastroenterol Disord 2004; 4[suppl 1]:S31-S38
14. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56:918-928
15. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15:270-285
16. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202:401-407
17. Llovet JM, Fuster J, Bruix J, Barcelona-Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004; 10[2suppl 1]:S115-S120
18. Roayaie S, Frischer JS, Emre SH, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 2002; 235:533-539
19. Venook AP, Ferrell LD, Roberts JP, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995; 1:242-248
20. Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9:557-563
21. Gazelle GS, Goldberg SN, Solbitati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217:633-646
22. McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: current status. AJR 2001; 176:3-16
23. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768
24. Fontana RJ. Management of patients with decompensated HBV cirrhosis. Semin Liver Dis 2003; 23:89-100
25. Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001; 34:411-416
26. Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 1999; 10:907-916
27. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441-451
28. Yao FY, Bass NM, Nikolai B, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9:684-692
29. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661
30. The Cancer of the Liver Italian program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28:751-755
31. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19:329-338
32. Cillo U, Bassanello M, Vitale A, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004; 40:124-131
33. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR 1998; 170:1015-1022
34. Ueno S, Tanabe G, Nuruki K, et al. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg 2002; 9:469-477
35. Yamashita Y, Torashima M, Ognuni T, et al. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation. Abdom Imaging 1993; 18:352-356
36. Khan KN, Nakata K, Kusumoto Y, et al. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma. Cancer Res 1991; 51:5667-5671